Trexquant Investment LP
- SEC CIK
- 0001633445
- Latest filing
- Aug 14, 2026
DSGN holding history
Design Therapeutics, Inc. in every 13F filed by Trexquant Investment LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
DSGN overviewAll 13F holders of DSGNFull Q2 2026 holdings
- Shares (Q2 2026)
- 28,150
- Value
- $407.3K
- % of portfolio
- <0.1%
- Quarters held
- 6
- Since Q3 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 28,150 | $407.3K | <0.1% | −88,961−76.0% | Reduced | Holders |
| Q1 2026 | 117,111 | $1.25M | <0.1% | +17,144+17.1% | Added | Holders |
| Q4 2025 | 99,967 | $937.7K | <0.1% | +99,967 | New | Holders |
| Q3 2023 | 0 | $0 | 0.0% | −46,524−100.0% | Sold out | Holders |
| Q2 2023 | 46,524 | $293.1K | <0.1% | −4,315−8.5% | Reduced | Holders |
| Q1 2023 | 50,839 | $293.3K | <0.1% | +50,839 | New | Holders |
| Q4 2022 | 0 | $0 | 0.0% | −11,296−100.0% | Sold out | Holders |
| Q3 2022 | 11,296 | $189.0K | <0.1% | +11,296 | New | Holders |